The National Cancer Institute (NCI) is offering a grant to establish the Experimental Therapeutics Clinical Trials Network (ET-CTN) for conducting early phase clinical trials. This grant aims to support multidisciplinary groups in defining drug development plans and conducting experimental therapeutic trials linked to Investigational New Drug (IND) applications. The network will collaborate on investigational agent-specific projects under NCIs Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program. Applications for UM1 cooperative agreements are invited until August 23, 2013.
Opportunity ID: 219835
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | RFA-CA-13-006 |
| Funding Opportunity Title:: | NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis (ET-CTN) (UM1) |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Education |
| Category Explanation:: | |
| Expected Number of Awards:: | 10 |
| Assistance Listings Number(s):: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 1 |
| Posted Date:: | Feb 08, 2013 |
| Last Updated Date:: | |
| Original Closing Date for Applications:: | Aug 23, 2013 |
| Current Closing Date for Applications:: | Aug 23, 2013 |
| Archive Date:: | Sep 23, 2013 |
| Estimated Total Program Funding:: | $ 8,500,000 |
| Award Ceiling:: | $850,000 |
| Award Floor:: | $ |
Eligibility
| Eligible Applicants:: | Small businesses |
| Additional Information on Eligibility:: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply but only if they are based in Canada. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply except for Canadian components. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name:: | National Institutes of Health |
| Description:: | The purpose of this Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI) is to support an experimental therapeutics clinical trials program through the creation of a consolidated, integrated NCI Experimental Therapeutics-Clinical Trials Network (ET-CTN). This FOA solicits UM1 cooperative agreement applications for multidisciplinary groups that will conduct early phase experimental therapeutics clinical trials. Members of the ET-CTN will work on investigational agent-specific trans-network project teams to define the drug development plan, and to conduct experimental therapeutic clinical trials filed to the Investigational New Drug (IND) applications by NCIs Division of Cancer Treatment and Diagnosis (DCTD), Cancer Therapy Evaluation Program (CTEP). |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Synopsis 1 |
Package Status
Package No: 1